Spravato esketamine nasal spray treatment at Physicians Ketamine Institute of Destin in Destin FL

Spravato Treatment in Destin, FL

FDA-approved esketamine nasal spray for treatment-resistant depression, administered in our Destin office and covered by most major insurance plans.

Book Now

Treatment Time:About 2.5 hours

Results Onset:Hours to days

Sessions Needed:Twice weekly, weeks 1-4

FDA Status:FDA approved 2019

Insurance-Covered Relief for Treatment-Resistant Depression

At Physicians Ketamine Institute of Destin, Dr. Megan Barnett, MD, Board-Certified Anesthesiologist, combines 15+ years of clinical expertise with the full spectrum of ketamine-based medicine, from IV infusions to FDA-approved esketamine, to help patients who have run out of options with standard antidepressants.

Spravato treatment in Destin, FL is an FDA-approved esketamine nasal spray for treatment-resistant depression, administered in our office under medical supervision and covered by most major insurance plans. At Physicians Ketamine Institute of Destin, we provide Spravato for patients across Destin, Fort Walton Beach, Niceville, Crestview, and surrounding Gulf Coast communities. If two or more antidepressants have failed to bring you relief, Spravato offers a clinically proven path forward, without the out-of-pocket burden of self-pay treatment.

Dr. Megan Barnett received her medical degree from Loma Linda University School of Medicine, where the paradigm emphasizes treating patients as a whole rather than physical ailments in isolation. She completed her anesthesiology residency at the University of California, San Diego, and practiced for over a decade primarily in the military setting as an active-duty Air Force anesthesiologist.

Her deployed combat experience gave her firsthand exposure to PTSD, anxiety, depression, and the chronic pain conditions that accompany traumatic injury and military service. She obtained additional certification in ketamine administration for mental health and pain disorders through the Integrative Psychiatry Institute in 2021 and maintains active membership in the American Society of Ketamine Physicians (ASKP).

Dr. Barnett is deeply inspired by the life-changing results she has witnessed in her clinic. She considers it the highest honor to care for patients when they are at their most vulnerable, and she is committed to helping each person become the best version of themselves.

Before and after Spravato treatment results showing mood improvement at PKI Destin in Destin FL

Understanding Treatment-Resistant Depression

If you have cycled through two, three, or more antidepressants and still feel like yourself only on the good days, you are not out of options and you are not alone. Roughly one in three people treated for major depression does not respond adequately to standard oral antidepressants. Clinicians call this treatment-resistant depression, and it is the exact situation Spravato was developed and approved for.

Traditional antidepressants work gradually on serotonin and related systems, and each new trial can take six to eight weeks before you know whether it helped. Spravato works on a different brain system entirely, which is why it can succeed where several medications in a row have not. Because esketamine carries a specific FDA approval for depression rather than an off-label designation, it is also the first ketamine-based treatment that most major insurance plans will cover, so the path forward does not depend on paying out of pocket.

Spravato esketamine nasal spray device used for treatment-resistant depression at PKI Destin FL

Understanding Your Treatment

What Is Spravato (Esketamine)?

The Science of Glutamate Modulation

Spravato is the brand name for esketamine, a nasal spray derived from ketamine and approved by the FDA in 2019 for treatment-resistant depression. Rather than targeting serotonin, esketamine acts on the glutamate system of the brain, the network most involved in forming and strengthening neural connections. By blocking NMDA receptors, it triggers a cascade that helps the brain restore synaptic connections in mood circuits that chronic depression has weakened.

Esketamine treatment is not a take-home prescription. Because of its effects during the dosing session, Spravato is administered only in certified treatment centers under a federal safety program called REMS. You take the spray yourself, in our office, with our medical team monitoring you afterward. It is typically prescribed together with an oral antidepressant.

Unlike our IV ketamine infusions, which are an off-label use of generic ketamine, Spravato carries a specific FDA approval for depression, granted on the strength of full clinical trials in treatment-resistant depression. That approval is what makes insurance coverage possible.

Treatment Timeline

Induction Phase

Twice weekly, weeks 1 through 4

Weeks 5 to 8

Once weekly

Maintenance

Every one to two weeks from week 9

Visit Length

About 2.5 hours including observation

Abstract neural network background representing esketamine therapy for depression in Destin FL

Treatment-Resistant Depression

Adults with major depressive disorder who have not responded to two or more antidepressants

Acute Suicidal Ideation

Depressive symptoms with acute suicidal thoughts or behavior, alongside psychiatric care

Persistent Low Mood

Depressed mood that has stayed fixed through multiple medication trials

Loss of Interest

Anhedonia, the flattened response to things that once brought pleasure

Depressive Fatigue

Low energy and daytime exhaustion tied to major depressive disorder

Concentration Difficulty

Trouble focusing and thinking clearly as part of a depressive episode

Key Advantages

Benefits of Spravato

Covered, Fast-Acting, Evidence-Based

Patient consultation about Spravato esketamine treatment at Physicians Ketamine Institute Destin

01

Covered by Insurance

Most major plans cover Spravato, and our team verifies benefits and handles prior authorization
02

FDA-Approved

Esketamine completed full clinical trials for depression and earned a specific FDA approval
03

Rapid Relief

Many patients notice improvement within hours to days of their first Spravato sessions
04

In-Office Medical Supervision

Every session is monitored by our medical team in our Destin office, never on your own
05

Works With Your Antidepressant

Taken alongside an oral antidepressant, so you build on the treatment you already have

Treatment	Mechanism	Time	Results	Duration	Downtime	Best For
Spravato (Esketamine)	NMDA receptor modulation, nasal spray	About 2.5 hours per visit	Hours to days	Maintenance every 1-2 weeks	2-hour observation, no driving	FDA-approved treatment-resistant depression with insurance coverage
IV Ketamine	NMDA receptor modulation, full molecule	40-60 minutes	Hours to days	Maintenance every 3-6 weeks	30-45 min recovery, no driving	Individualized dosing, non-response to esketamine, chronic pain
TMS Therapy	Magnetic brain stimulation	20-40 minutes	Weeks 2 to 4	12 months or longer	None	Drug-free, insurance-covered depression treatment
Oral Antidepressants	Serotonin and norepinephrine reuptake	Daily at home	4-8 weeks	Ongoing daily use	None	First and second-line treatment for depression

Confident adult patient considering Spravato treatment at Physicians Ketamine Institute Destin FL

Is Spravato Right for You?

Who Is a Good Candidate for Spravato?

Candidacy and Safety Considerations

Spravato is designed for adults whose depression has not responded to standard oral antidepressants. Dr. Barnett reviews your full medical and psychiatric history before any treatment is scheduled.

Ideal Candidates for Spravato

Adults diagnosed with major depressive disorder
Patients who have tried at least two antidepressants without adequate relief
Patients who want a treatment their insurance can cover
Adults whose depression includes acute suicidal thoughts and who need relief faster than oral medication can provide
Veterans navigating VA coverage, a group we work with regularly
Patients willing to continue an oral antidepressant alongside treatment

Who Should Wait or Avoid Spravato

Aneurysmal vascular disease or arteriovenous malformation
History of bleeding in the brain
Known allergy to ketamine or esketamine
Uncontrolled high blood pressure, which must be managed first
Pregnancy, during which treatment is not recommended

These are absolute or conditional contraindications depending on your history, and every patient is medically cleared before a first dosing session is booked.

Your Experience

Spravato Treatment Overview

Consultation and Insurance Verification

Your first visit covers your medical and treatment history, confirms that Spravato fits your situation, and starts the insurance work so you know your costs before your first dosing session.

Self-Administered Dosing

At each session, you self-administer the nasal spray under the direct guidance of our team. The process itself takes only a few minutes.

Two-Hour Monitoring

You relax in a private room while we monitor you for about two hours, checking blood pressure and making sure any temporary effects settle before you leave.

Going Home

You will need someone to drive you home after each session, and most patients return to normal activities the next morning.

Safety and clinical monitoring information for Spravato esketamine treatment at PKI Destin FL

Safety Information

Risks and Side Effects of Spravato

What to Know

Spravato is administered in our Destin office under the supervision of Dr. Megan Barnett, MD, a board-certified anesthesiologist. Every dose is followed by in-office monitoring, which is exactly why the temporary effects of esketamine are managed safely rather than experienced alone at home.

Common Side Effects

Dissociation, a temporary dreamlike or detached feeling during the session
Dizziness and drowsiness for the remainder of the session
Nausea, which can be managed with medication
A short-lived rise in blood pressure, monitored throughout observation

Less Common Side Effects

Headache following the session
Numbness or altered taste in the nose and mouth
Anxiety as the dose takes effect, typically settling within the observation period

These effects appear during or shortly after the session and typically resolve the same day. Because esketamine is a controlled substance, the REMS program also ensures the medication is never dispensed for home use. Serious complications are rare in the certified-center setting, and our anesthesiology-led team is equipped to manage side effects immediately if they arise.

Pricing and Payment Options

Because Spravato is insurance-covered, your cost depends on your plan, your deductible, and your copay rather than on a flat cash price. For most covered patients, out-of-pocket costs are a fraction of what self-pay ketamine treatments cost.

Insurance Coverage

Spravato is covered by most major insurance plans for treatment-resistant depression, including Medicare, Tricare, Blue Cross Blue Shield, Aetna, and UnitedHealthcare. Our team will verify your insurance benefits, handle prior authorization, and help determine your out-of-pocket costs before treatment begins. Commercially insured patients may also qualify for the manufacturer copay support program, which can reduce per-session medication costs significantly.

Payment Options

Physicians Ketamine Institute of Destin is a VA Community Care Partner, which means eligible veterans may receive coverage through the VA healthcare system. We also accept Health Savings Account (HSA) and Flexible Spending Account (FSA) payments. Please contact our office at (850) 598-0099 with any questions about coverage or costs.

Modern clinic interior at Physicians Ketamine Institute of Destin in Destin Florida

Physician-Led Care

Dr. Barnett, a board-certified anesthesiologist, oversees every Spravato dosing session

Certified Spravato Treatment Center

Our office meets every federal REMS requirement, from secure handling to post-dose observation

The Full Spectrum of Ketamine Medicine

Spravato and IV ketamine under one roof, so we can pivot without sending you elsewhere

Veteran-Friendly and VA Community Care Partner

Dr. Barnett served as an active-duty Air Force anesthesiologist. We work with Tricare and the VA

Ketamine Therapy

Neuromodulation

IV Wellness

01 Is Spravato covered by insurance?

Yes. Spravato is FDA-approved for treatment-resistant depression, and most major plans cover it, including Medicare, Tricare, Blue Cross Blue Shield, Aetna, and UnitedHealthcare. Our team verifies your specific benefits and handles prior authorization before your first session.

02 How much does Spravato cost with insurance?

Your cost depends on your plan, deductible, and copay. Many commercially insured patients also qualify for the manufacturer copay program, which can lower per-session costs substantially. We give you a clear cost estimate before treatment begins, so there are no surprises.

03 What is the difference between Spravato and ketamine infusions?

Spravato is esketamine, an FDA-approved nasal spray that insurance covers for treatment-resistant depression. IV ketamine uses the full ketamine molecule, allows precise dose adjustment, and is used off-label, which usually means self-pay. We offer both and recommend based on your history, coverage, and response.

04 How long does a Spravato session take?

Plan for about two and a half hours. The spray itself takes minutes, and the rest is the required two-hour monitoring period, which you spend relaxing in a private room.

05 Can I drive myself home after treatment?

No. You will need a ride home after each session and should not drive until the next day, after a restful night of sleep.

06 Do I keep taking my antidepressant during Spravato treatment?

In most cases, yes. Spravato is approved for use together with an oral antidepressant, and Dr. Barnett coordinates your treatment plan with your prescribing provider.

Location1241 Airport Rd, Suite A
Destin, FL, 32541

EmailPKIofDestin@yahoo.com

Phone(850) 598-0099

Ready to Start?

Schedule Your Spravato Consultation

References

Popova V, Daly EJ, Trivedi M, et al. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study (TRANSFORM-2). Am J Psychiatry. 2019;176(6):428-438. PMID: 31109201. Flexibly dosed esketamine nasal spray plus a newly initiated oral antidepressant produced significantly greater symptom improvement than the antidepressant alone in treatment-resistant depression.
Daly EJ, Trivedi MH, Janik A, et al. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression (SUSTAIN-1). JAMA Psychiatry. 2019;76(9):893-903. PMID: 31166571. Continued esketamine treatment significantly delayed relapse in patients who had achieved stable remission or stable response.
Fu DJ, Ionescu DF, Li X, et al. Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE-1). J Clin Psychiatry. 2020;81(3):19m13191. PMID: 32412700. Esketamine nasal spray added to comprehensive standard of care reduced depressive symptoms within 24 hours in patients with active suicidal ideation with intent.
U.S. Food and Drug Administration. (2019). FDA approved esketamine nasal spray for treatment-resistant depression, available only at certified treatment centers under a Risk Evaluation and Mitigation Strategy program.